Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Borate + sodium chloride** is a combination of the inorganic salts borate (commonly as sodium borate, also known as borax) and sodium chloride (table salt)[2][3][9][10]. This combination does not correspond to a single, widely approved pharmaceutical entity, but it is used in multi-ingredient products, notably as a component in ophthalmic (eye) solutions and contact lens rinses, often alongside boric acid for its buffering, tonicity, and mild antiseptic properties[7]. **Mechanism of action:** - **Sodium borate (borate):** Acts as a buffer, helping to maintain pH, and demonstrates mild antiseptic and antifungal effects by disrupting microbial cell membranes[3][5]. - **Sodium chloride:** Provides isotonicity to solutions by matching the osmolarity of bodily fluids such as tears, and it maintains electrolyte balance[9]. This combination is used primarily for its physical-chemical properties rather than any synergistic pharmacologic activity. **Primary indication**: Used in products for eye care (e.g., contact lens solutions, ophthalmic irrigation) as a buffering, tonicity, and mild antiseptic agent[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on borate + sodium chloride.